Supplemental material
Open access
1,493
Views
16
CrossRef citations to date
0
Altmetric
Research Article
A new nitrobenzoxadiazole-based GSTP1-1 inhibitor with a previously unheard of mechanism of action and high stability
Chiara FulciDepartment of Experimental Medicine and Surgery, University of Tor Vergata, Rome, Italy; View further author information
, Dante RotiliDepartment of Drug Chemistry and Technologies, University of Rome “Sapienza”, Rome, Italy;
http://orcid.org/0000-0002-8428-8763View further author information
Anastasia De LucaDepartment of Experimental Medicine and Surgery, University of Tor Vergata, Rome, Italy; View further author information
, Lorenzo StellaDepartment of Chemical Sciences and Technologies;
http://orcid.org/0000-0002-5489-7381View further author information
Blasco Morozzo della RoccaDepartment of Biology, University of Tor Vergata, Rome, Italy; View further author information
, Mariantonietta ForgioneDepartment of Drug Chemistry and Technologies, University of Rome “Sapienza”, Rome, Italy; View further author information
, Veronica Di PaoloDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy; View further author information
, Antonello MaiDepartment of Drug Chemistry and Technologies, University of Rome “Sapienza”, Rome, Italy; ;Pasteur Institute, Cenci Bolognetti Foundation, University of Rome “La Sapienza”, Rome, Italy; View further author information
, Mattia FalconiDepartment of Biology, University of Tor Vergata, Rome, Italy; View further author information
, Luigi QuintieriDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy; View further author information
& Anna M. CaccuriDepartment of Experimental Medicine and Surgery, University of Tor Vergata, Rome, Italy; ;The NAST Centre for Nanoscience & Nanotechnology & Innovative Instrumentation, University of Tor Vergata, Rome, ItalyCorrespondence[email protected]
View further author information
show allView further author information
Pages 240-247
|
Received 28 Jul 2016, Accepted 20 Sep 2016, Published online: 18 Jan 2017
Related Research Data
The fine-tuning of TRAF2-GSTP1-1 interaction: effect of ligand binding and in situ detection of the complex.
Source:
Springer Science and Business Media LLC
In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma
Source:
Elsevier BV
7-nitro-2,1,3-benzoxadiazole derivatives, a new class of suicide inhibitors for glutathione S-transferases : Mechanism of action of potential anticancer drugs
Source:
Elsevier BV
Fluorescence quenching and ligand binding: A critical discussion of a popular methodology
Source:
Elsevier BV
New Insights into the Mechanism of JNK1 Inhibition by Glutathione Transferase P1-1
Source:
American Chemical Society (ACS)
Synthesis and structure--activity relationship of new cytotoxic agents targeting human glutathione-S-transferases.
Source:
Elsevier BV
Proapoptotic activity of new glutathione S-transferase inhibitors.
Source:
American Association for Cancer Research (AACR)
Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2–ASK1 signals
Source:
Springer Science and Business Media LLC
Synthesis and characterisation of a new benzamide-containing nitrobenzoxadiazole as a GSTP1-1 inhibitor endowed with high stability to metabolic hydrolysis.
Source:
Informa UK Limited
Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines
Source:
Royal Society of Chemistry (RSC)
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.